Bulk Inquiry
Valdecoxib
- SC 65872 - Bextra- Soluble in DMSO
- MF: C16H14N2O3S
- MW: 314.36
Description
Valdecoxib (SC-65872) is a potent and highly selective cyclooxygenase-2 (COX-2) inhibitor with weak activity against COX-1. Reported IC50 values are 0.005 µM for COX-2 and 140 µM for COX-1 in human enzyme/whole-blood assay settings.
COX-2 is an inducible enzyme in prostaglandin biosynthesis and a central pharmacological target in inflammation and pain pathways. Valdecoxib is useful as a selective NSAID reference for separating COX-2-driven biology from COX-1 activity.
Key Features
- Highly selective COX-2 inhibitor
- Weak inhibitory activity against COX-1
- Blocks prostaglandin synthesis pathways
- Useful NSAID reference compound
Applications
- COX-2 pharmacology studies
- Inflammation and pain pathway research
- Prostaglandin biosynthesis assays
- COX selectivity profiling
More Information
| Parent CAS No. | 181695-72-7 |
|---|---|
| Chemical Name | 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide |
| extra_info | . |
| SMILES | C1(S(N)(=O)=O)=CC=C(C2=C(C)ON=C2C2=CC=CC=C2)C=C1 |
| MFCD | MFCD00950568 |
| InChi | InChI=1S/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20) |
| InChiKey | LNPDTQAFDNKSHK-UHFFFAOYSA-N |
| CID | 119607 |
| Short Description | COX-2 inhibitor |
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 1523 | Pravadoline |
From $77.00 |
| 1919 | Celecoxib |
From $55.00 |
| 1974 | GW 406381 |
From $132.00 |
| 2108 | SC 236 |
From $88.00 |
| 2288 | ATB 346 |
From $121.00 |
| 2312 | ML 351 |
From $137.50 |
| 3126 | Flurbiprofen |
From $55.00 |
| 3176 | Diethylcarbamazine citrate |
From $55.00 |
| 3311 | Parecoxib sodium |
From $55.00 |
| 3318 | Indomethacin |
From $55.00 |
| 3364 | Naproxen sodium |
From $55.00 |
| 3374 | Nepafenac |
From $55.00 |
| 3376 | Rofecoxib |
From $66.00 |
| 3448 | Diflunisal |
From $55.00 |
| 3451 | Etodolac |
From $55.00 |
| 3712 | Isoxicam |
From $55.00 |
| 3818 | Oxaprozin |
From $88.00 |
| 3885 | Etoricoxib |
From $99.00 |


